Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines

Cancer Research

Volumn 56, Issue 23, 1996, Pages 5319-5324

  Glinsky, Gennadi V ^a,b,c,d,f   Price, Janet E ^e   Glinsky, Vladislav V ^a,b   Mossine, Valery V ^b   Kiriakova, Galina ^e   Metcalf, John B ^c,d  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c Metastat Inc   (United States)

^d MetaStat Inc   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; AMINOSUGAR; N (1 DEOXYFRUCTOS 1 YL) DEXTRO LEUCINE; N (1 DEOXYFRUCTOS 1 YL)PHENYLALANINE; N (1 DEOXYLACTULOS 1 YL)LEUCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

AMINO ACIDS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GLYCOCONJUGATES; HUMANS; LECTINS; LEUCINE; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PEANUT AGGLUTININ; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0030453239     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Howe, G. R., Hirohata, T., Hislop, T. G., Iscovich, J M , Yuan, J-M., Katsouyami, K , Lubin, F., Marubini, E., Modan, B., Rohan, T., Toniolo, P., and Shunzhang, Y. Dietary factors and risk of breast cancer, combined analysis of 12 case-control studies. J Natl. Cancer Inst., 82: 561-569, 1990.
2. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics, 1995. CA Cancer J Clin., 45: 8-30, 1995.
3. Harris, J. R., Lippman, M E., Veronesi, U., and Willett, W. Breast cancer (part 1). N. Engl. J. Med., 327. 319-328, 1992.
4. Nomura, Y., Tashiro, H., and Hisamatsu, K In vitro clonogenic growth and metastatic potential of human operable breast cancer. Cancer Res., 49: 5288-5293, 1989.
5. Hug, V., Rashid, R., Johnston, D., and Hortobagyi, G Clonogenic growth and hormone sensitivity of benign and malignant breast tissues. Br. J. Cancer, 56: 619-621, 1987.
6. Cifone, M. A., and Fidler, I. J. Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma. Proc Natl. Acad. Sci USA, 77: 1039-1043, 1980.
7. Price, J. E. Clonogenicity and experimental metastatic potential of spontaneous mouse mammary neoplasms. J. Natl. Cancer Inst., 77: 529-535, 1986.
8. Saiga, T., Kashu, I., Tabuchi, K., et al. Increased contraenvironmental pressure division capability: a decisive force in metastasis and invasion of mouse lung adenocarcinoma cell lines. Invasion & Metastasis, 9. 254-268, 1989
9. Fidler, I. J., Li, L , Ananthaswamy, H., Esumi, N., Radinsky, R., and Price, J E Correlation of growth capacity in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites. Anticancer Res , 11. 17-24, 1991.
10. Li, L., Price, J E , Fan, D., Zhang, R. D., Bucana, C. D., and Fidler, I. J. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites. J Natl. Cancer Inst., 81 1406-1412, 1989.
11. Zhang, R. D., Fidler, I. J., and Price, J. E Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis Invasion & Metastasis, 11: 204-215, 1991.
12. Zhang, R. D , Price, J. E., Schackert, G., Itoh, K., and Fidler, I. J. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis. Cancer Res., 51: 2029-2035, 1991.
13. Glinsky, G. V. Glycoamines. Biochemistry of a new class of humoral tumor markers. J. Tumor Markers Oncology, 4: 193-221, 1989.
14. Glinsky, G. V. Glycoamines. Structural-functional characterization of a new class of humoral tumor markers In: S Sell (ed), Serological Cancer Markers, pp 233-260. Totowa, NJ: The Humana Press, 1992
15. Kuo, K C., Gehrke, J. C., Allen, W. C., Holsbeke, M., Li, Z , Glinsky, G V., Zumwalt, R. W., and Gehrke, C W High-performance liquid chromatographic analysis of glycoamines in serum J. Chromatogr , 656: 295-302, 1994.
16. Glinsky, G. V., Linetsky, M. D., Shemyakin, V. V , Markin, V. V., Liventsov, V. V , and Ivanova, A. B. Structural analysis of a new class of humoral tumor markers: characterization of 48 aminoglycoconjugates (glycoamines) isolated from rat and human blood plasma J Tumor Markers Oncology, 5: 107-118, 1990.
17. Glinsky, G. V., and Linetsky, M. D Structural analysis of the carbohydrate core of amino-glycoconjugates (glycoamines) from blood plasma of oncological patients J Tumor Markers Oncology, 5: 137-160, 1990.
18. Glinsky, G. V., Linetsky, M D., Liventsov, V. V., Surmilo, N. I , Ivanova, A. B , Sidorenko, M. V., and Vinnitsky, V. B. Glycoamine-synthesizing reaction, molecular mechanism of the incorporation of monomers into aminoglycoconjugates J Tumor Markers Oncology, 5: 119-136, 1990
19. Glinsky, G. V. Cell adhesion and metastasis: is the site specificity of cancer metastasis determined by leukocyte-, endothelial cell recognition and adhesion? Crit. Rev. Oncol Hematol , 14: 229-278, 1993.
20. Glinsky, G. V. Glycodeterminants of melanoma cell adhesion. A model for antimetastatic drug design. Crit Rev Oncol Hematol., 14: 1-13, 1993.
21. Glinsky, G. V The blood group antigen-related glycoepitopes: biological functions and implications in immunogenesis, cancer, and AIDS pathogenesis. The Medical Intelligence Units. Austin, TX: RG Landes Co., 1992.
22. Glinsky, G. V. The blood group antigens (BGA)-related glycoepitopes. A key structural determinant in immunogenesis and cancer pathogenesis Crit. Rev. Oncol. Hematol , 12. 151-166, 1992.
23. Mossine, V. V., Glinsky, G. V , and Feather, M. S. The preparation and characterization of some Amadori compounds (1-amino-1-deoxy-D-fructose derivatives) derived from a series of aliphatic ω-amino acids. Carbohydr. Res., 262: 257-270, 1994.
24. Mossine, V. V., Glinsky, G. V., Barnes, C. L., and Feather, M. S. Crystal structure of an Amadori compound N-(1-Deoxy-β-D-fructopyranos-1-yl)-glycine ("D-fructose-glycine") Carbohydr. Res , 266: 5-14, 1995.
25. Glinsky, G V , Mossine, V. V., Price, J. E., Bielenberg, D., Glinsky, V V., Ananthaswamy, H. N., and Feather, M. S. Inhibition of colony formation inagarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs Clin. & Exp. Metastasis, 14: 253-267, 1996.
26. Price, J. E., Polyzos, A., Zhang, R. D., and Daniels, L M. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res., 50: 717-721, 1990.
27. Fidler, I. J. The relationship of embolic homogeneity, number, size, and viability to the incidence of experimental metastasis. Eur. J Cancer, 9: 223-227, 1973.
28. Fidler, I J Selection of successive tumor lines for metastasis. Nat. New Biol., 242: 148-149, 1973.
29. Fidler, I. J. Biological behavior of malignant melanoma cells correlated to their survival in vivo Cancer Res , 35: 218-224, 1975.
30. Hart, I R. The selection and characterization of an invasive variant of the B16 melanoma. Am J Pathol., 97. 587-592, 1979.
31. Zar, J. H. Biostatistical analysis. 2nd Ed. Englewood Cliffs, NJ: Prentice-Hall, Inc , 1984.
32. Glinsky, G V., and Glinsky, V V. Apoptosis and metastasis: a superior resistance of metastatic cancer cells to programmed cell death. Cancer Lett , 101: 43-51, 1996.
33. Meromsky, L., Lotan, R., and Raz, A. Implications of endogenous tumor cell surface lectins as mediators of cellular interactions and lung colonization. Cancer Res., 46: 5270-5275, 1986.
34. Pienta, K J., Naik, H , Akhtar, A , Yamazaki, K., Replogle, T. S , Lehr, J , Donat, T. L., Tait, L., Hogan, V , and Raz, A. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst , 87: 348-353, 1995.